News

Filter

Current filters:

USARanbaxy Laboratories

1 to 9 of 10 results

District Court rules not to prevent Dr Reddy's and Endo from challenging Ranbaxy

District Court rules not to prevent Dr Reddy's and Endo from challenging Ranbaxy

21-11-2014

Indian pharma company Ranbaxy has been denied its request to prevent the US Food and Drug Administration…

Anti-viralsDr Reddy's LaboratoriesEndo InternationalGastro-intestinalsGenericsLegalNexiumRanbaxy LaboratoriesUSAValcyte

FDA revokes tentative approval of Ranbaxy’s generic Nexium and Valcyte

07-11-2014

Indian generics drugmaker Ranbaxy Laboratories revealed in a Bombay Stock Exchange filing that it has…

Anti-viralsAstraZenecaGastro-intestinalsGenericsNexiumPfizerRanbaxy LaboratoriesRegulationSun PharmaceuticalUSAValcyte

US regulatory warnings on drug producers extend well beyond India

US regulatory warnings on drug producers extend well beyond India

14-07-2014

Hauled up by the US Food and Drug Administration for product recalls and quality issues, Indian pharmaceutical…

CiplaDr Reddy's LaboratoriesGenericsIndiaLupinProductionRanbaxy LaboratoriesRegulationSun PharmaceuticalUSA

Sun Pharma vows “appropriate action” as Ranbaxy merger halted

05-05-2014

In the wake of a suspension of its proposed $4 billion acquisition of domestic rival Ranbaxy Laboratories…

GenericsIndiaMergers & AcquisitionsProductionRanbaxy LaboratoriesSun Pharmaceutical IndustriesUSA

Ranbaxy recalls Lipitor generic over dose error

Ranbaxy recalls Lipitor generic over dose error

10-03-2014

India’s largest drugmaker Ranbaxy Laboratories (BSE: 500359) has recalled more than 64,000 bottles…

Atorvastatin CalciumCardio-vascularIndiaLipitorPharmaceuticalRanbaxy LaboratoriesRegulationUSA

India and the USA need to collaborate

India and the USA need to collaborate

14-02-2014

Here's our take on the week's top stories.

IndiaPharmaceuticalRanbaxy LaboratoriesRegulationUSAWockhardt

1 to 9 of 10 results

Back to top